Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

Several years ago, my insurance plan would only cover Admelog insulin to treat my type 1 diabetes, which caused my blood sugar to hover high for months. In the long term, prolonged high blood sugars ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...